Terms: = Breast cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6
27 results:
1. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
2. Detection of Circulating Tumor Cell-Related Markers in Gynecologic cancer Using Microfluidic Devices: A Pilot Study.
Law KS; Huang CE; Chen SW
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768623
[TBL] [Abstract] [Full Text] [Related]
3. BC-DETECT: combined detection of serum he4 and TFF3 improves breast cancer diagnostic efficacy.
Abdelrazek MA; Nageb A; Barakat LA; Abouzid A; Elbaz R
Breast Cancer; 2022 May; 29(3):507-515. PubMed ID: 34994942
[TBL] [Abstract] [Full Text] [Related]
4. Serum Human Epididymis Protein-4 (he4) - A novel Approach to Differentiate Malignant Frombenign breast Tumors.
Sai Baba KSS; Rehman MA; Pradeep Kumar J; Fatima M; Raju GSN; Uppin SG; Mohammed N
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2509-2507. PubMed ID: 34452565
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic value of serum human epididymis protein 4 and cancer antigen 125 in the patients with ovarian carcinoma: A protocol for systematic review and meta-analysis.
Dai HY; Hu F; Ding Y
Medicine (Baltimore); 2021 May; 100(21):e25981. PubMed ID: 34032711
[TBL] [Abstract] [Full Text] [Related]
6. A strengthening the reporting of observational studies in epidemiology (STROBE): Are he4 and CA 125 suitable to detect a Paget disease of the vulva?
Dellino M; Gargano G; Tinelli R; Carriero C; Minoia C; Tetania S; Silvestris E; Loizzi V; Paradiso A; Casamassima P; Tufaro A; Cormio G; Garrisi VM
Medicine (Baltimore); 2021 Feb; 100(5):e24485. PubMed ID: 33592901
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of serum human epididymis protein 4 in patients with relapsing-remitting multiple sclerosis.
Adamczyk B; Partyka R; Adamczyk-Sowa M; Wierzbicki K; Sowa P; Kokocińska D
Adv Clin Exp Med; 2020 Aug; 29(8):943-948. PubMed ID: 32790249
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer.
Akoz G; Diniz G; Ekmekci S; Ekin ZY; Uncel M
Indian J Pathol Microbiol; 2018; 61(3):323-329. PubMed ID: 30004048
[TBL] [Abstract] [Full Text] [Related]
9. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract] [Full Text] [Related]
10. The clinical significance of DJ-1 and he4 in patients with endometrial cancer.
Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
[TBL] [Abstract] [Full Text] [Related]
11. Combined detection of plasma miR-127-3p and he4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract] [Full Text] [Related]
12. Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.
Weinberger V; Bednarikova M; Cibula D; Zikan M
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1311-1321. PubMed ID: 27732120
[TBL] [Abstract] [Full Text] [Related]
13. The Use of breast Magnetic Resonance Imaging Parameters to Identify Possible Signaling Pathways of a Serum Biomarker, he4.
Durur-Karakaya A; Durur-Subasi I; Karaman A; Akcay MN; Palabiyik SS; Erdemci B; Alper F; Acemoglu H
J Comput Assist Tomogr; 2016; 40(3):436-41. PubMed ID: 27192502
[TBL] [Abstract] [Full Text] [Related]
14. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.
Urban N; Hawley S; Janes H; Karlan BY; Berg CD; Drescher CW; Manson JE; Palomares MR; Daly MB; Wactawski-Wende J; O'Sullivan MJ; Thorpe J; Robinson RD; Lane D; Li CI; Anderson GL
Gynecol Oncol; 2015 Nov; 139(2):253-60. PubMed ID: 26343159
[TBL] [Abstract] [Full Text] [Related]
15. Fabrication of plasmon length-based surface enhanced Raman scattering for multiplex detection on microfluidic device.
Nguyen AH; Lee J; Il Choi H; Seok Kwak H; Jun Sim S
Biosens Bioelectron; 2015 Aug; 70():358-65. PubMed ID: 25841120
[TBL] [Abstract] [Full Text] [Related]
16. Serum human epididymal protein 4 (he4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.
Stiekema A; Boldingh QJ; Korse CM; van der Noort V; Boot H; van Driel WJ; Kenter GG; Lok CA
Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808
[TBL] [Abstract] [Full Text] [Related]
17. he4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.
Jiang SW; Chen H; Dowdy S; Fu A; Attewell J; Kalogera E; Drapkin R; Podratz K; Broaddus R; Li J
Int J Mol Sci; 2013 Nov; 14(11):22655-77. PubMed ID: 24252907
[TBL] [Abstract] [Full Text] [Related]
18. Human epididymis protein 4 (he4) in benign and malignant diseases.
Hertlein L; Stieber P; Kirschenhofer A; Krocker K; Nagel D; Lenhard M; Burges A
Clin Chem Lab Med; 2012 Dec; 50(12):2181-8. PubMed ID: 23093276
[TBL] [Abstract] [Full Text] [Related]
19. Serum level of he4 is closely associated with pulmonary adenocarcinoma progression.
Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K
Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907
[TBL] [Abstract] [Full Text] [Related]
20. he4 in the differential diagnosis of a pelvic mass: a case report.
Anastasi E; Granato T; Coppa A; Manganaro L; Giannini G; Comploj S; Frati L; Midulla C
Int J Mol Sci; 2011 Jan; 12(1):627-32. PubMed ID: 21340004
[TBL] [Abstract] [Full Text] [Related]
[Next]
